Our mission is to make post-trade data reliable and automated with ISDA CDM-aligned golden records—benefiting all market participants and advancing capital markets toward transparency, efficiency, and cost-effectiveness. Today, the OTC derivatives market—despite trillions traded daily—still relies on legacy, manual, and fragmented post-trade processes. These outdated workflows drive escalating risk and cost for both buy side and sell side.

Fragmos Chain believes post-trade should be standardised, deterministic, and shared. We replace reconciliations and hand-offs with a digital-first fabric that transforms unstructured inputs into golden, machine-readable records to accelerate control, transparency and settlement. We’ve assembled top industry experts, partnered with Delta Capita—a leading capital-markets services and technology provider—and built on the ISDA CDM™, to which Fragmos is a leading contributor, delivering a powerful, reliable, long-term solution from day one.

Together with Delta Capita, we launched Elaris OTC, a multi-broker post-trade platform powered by Fragmos Chain. It enables buy-side and sell-side firms to move decisively toward industry-grade automation across confirmations, lifecycle events, and regulatory reporting. With our strategic partners, we’re already rolling this out through custom trials with early-adopter broker-dealers and buy-side firms.